🔎 Trials Near Me

Akèy › Neuroblastom › Tennessee

Etid klinik pou Neuroblastom nan Tennessee

12 etid pou Neuroblastom ap chèche patisipan nan sit nan Tennessee.

Vil nan Tennessee

Tèks ofisyèl etid la (Anglè)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

  • East Tennessee Childrens Hospital, Knoxville
  • Saint Jude Children's Research Hospital, Memphis
  • The Children's Hospital at TriStar Centennial, Nashville
  • ak 1 plis
Ap rekriteFaz 3
Jiska laj 30 · Tout sèks · Mizajou Oct 2, 2026 · NCT06172296

Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

  • Monroe Carrell Jr. Children's Hospital at Vanderbilt, Nashville
Ap rekriteFaz 1/2
Jiska laj 26 · Tout sèks · Mizajou Sep 3, 2026 · NCT06465199

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

  • Monroe Carrell Jr. Children's Hospital at Vanderbilt, Nashville
Ap rekriteFaz 1/2
Jiska laj 30 · Tout sèks · Mizajou Sep 3, 2026 · NCT06541262

Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma

  • Monroe Carrell Jr. Children's Hospital at Vanderbilt, Nashville
Ap rekriteFaz 2
Laj 1 a 21 · Tout sèks · Mizajou Sep 3, 2026 · NCT06540963

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

  • East Tennessee Childrens Hospital, Knoxville
  • Saint Jude Children's Research Hospital, Memphis
  • The Children's Hospital at TriStar Centennial, Nashville
  • ak 1 plis
Ap rekriteFaz 3
365 Days – 30 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT03126916

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • Saint Jude Children's Research Hospital, Memphis
Ap rekriteFaz 1/2
12 Months – 30 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT04851119

NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

  • St. Jude Children's Research Hospital, Memphis
Ap rekriteFaz 2
Laj 1 a 31 · Tout sèks · Mizajou Jul 20, 2026 · NCT06450041

Familial Investigations of Childhood Cancer Predisposition

  • St. Jude Children's Research Hospital, Memphis
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jun 17, 2026 · NCT03050268

B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

  • St. Jude Children's Research Hospital, Memphis
Ap rekriteFaz 1
Jiska laj 21 · Tout sèks · Mizajou May 19, 2026 · NCT04897321

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

  • St. Jude Children's Research Hospital, Memphis
Ap rekriteFaz 1/2
12 Months – 30 Years · Tout sèks · Mizajou May 19, 2026 · NCT04901702

Neuroblastoma Biology Study

  • St. Jude Children's Research Hospital, Memphis
Ap rekriteEtid obsèvasyon
31 Days – 99 Years · Tout sèks · Mizajou Mar 23, 2026 · NCT01587300

Molecular Analysis Of Solid Tumors

  • St. Jude Children's Research Hospital, Memphis
Ap rekriteEtid obsèvasyon
Jiska laj 25 · Tout sèks · Mizajou Nov 12, 2025 · NCT01050296

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.